StockNYSESOLV

Solventum

$88.59

+0.22 (+0.25%)today

Valuation & earnings

P/E ratio: 10.83
Forward P/E: 12.25
EPS (ttm): $8.18
Forward EPS: $7.23
Price/book: 3.14
PEG ratio: 1.22
Payout ratio: 0%

Financials (ttm)

Revenue (ttm): 8.3B
Revenue growth: 2.2%
Profit margin: 17.26%
Return on equity: 33.96%
Total cash: 403M
Total debt: 5.3B

Earnings (EPS)

Quarter	Estimate	Actual	Surprise
Sep 30, 2025	1.43	1.5	+4.73%
Dec 31, 2025	1.5	1.57	+5%
Mar 31, 2026	1.35	1.48	+9.33%
Jun 30, 2026	1.91	2.55	+33.78%

Next earnings date: Nov 5, 2026

Analyst view

Consensus ratingBuy15 analysts

Strong buy 1Buy 7Hold 5Sell 1Strong sell 1

12-month price targetsImplied upside: +6.02%

93.92

113

LowCurrent priceHigh

Key stats

Previous close: $88.37
Day range: 88.12 – 89.04
52-week range: 62.38 – 94.16
Volume: 635.8K
Avg. volume: 1.1M
Market cap: 15.1B
Beta: 0.69
52-week change: 24.13%
Currency: USD

Profile

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, an(English)

Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 20,584
Headquarters: Eagan, United States

Visit website

Market data provided by Yahoo Finance, may be delayed. For informational purposes only — not investment advice.